Stroke Risk Factors, Genetics, and Prevention

Amelia K Boehme1, Charles Esenwa1, Mitchell S V Elkind2

  • 1From the Department of Epidemiology, Mailman School of Public Health (A.K.B., M.S.V.E.) and Department of Neurology, College of Physicians and Surgeons (A.K.B., C.E., M.S.V.E.), Columbia University, New York, NY.

Circulation Research
|February 4, 2017
PubMed

Insights

Understanding stroke risk factors, both nonmodifiable and modifiable, is key to prevention. Recent research highlights genetic factors and environmental interactions, offering new avenues for targeted stroke prevention strategies.

Area of Science:

  • Neurology
  • Genetics
  • Public Health

Background:

  • Stroke is a complex condition with diverse causes and risk factors.
  • Risk factors are broadly classified as nonmodifiable (age, sex, race) and modifiable (hypertension, smoking, diet).
  • Emerging risk factors include inflammatory conditions, infections, pollution, and cardiac disorders.

Purpose of the Study:

  • To review and categorize stroke risk factors.
  • To explore the role of genetics and environmental interactions in stroke risk.
  • To discuss current and emerging stroke prevention strategies.

Main Methods:

  • Literature review of stroke pathogenesis, risk factors, and prevention.
  • Analysis of modifiable and nonmodifiable risk factors.
  • Examination of genetic polymorphisms and their influence on stroke risk.

Main Results:

  • Identified established modifiable and nonmodifiable risk factors for ischemic and hemorrhagic stroke.
  • Highlighted novel risk factors such as inflammatory disorders and pollution.
  • Emphasized the significant role of genetic factors and their interaction with the environment.

Conclusions:

  • Stroke prevention strategies should encompass lifestyle modifications and management of medical conditions.
  • Genetic factors, previously considered immutable, may offer modifiable targets for stroke prevention.
  • Targeted approaches based on identified risk factors and genetic predispositions can enhance stroke prevention efforts.

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
76
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.4K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
538
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
66
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.6K
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
432